Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell LineAlcides Euzebio Tavares Xavier, Carlos Alberto Scrideli|Cancers|2024Cited by 4